Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FU284
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,975
Award facts
- Contract value 100% obligated
- $23,975.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,975.10 to supply Fasenra Pen 30 mg/mL, a biologic medication used to treat severe asthma. The contract was awarded on December 1, 2025, with a completion date of December 22, 2025, and represents a firm fixed-price delivery order without a set-aside designation. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply support across military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare procurement. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic areas. As a non-small business entity, AmerisourceBergen consistently wins competitively awarded contracts and demonstrates capability to fulfill federal medical supply requirements. This particular delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through the flexible SPE2DX vehicle, which enables rapid fulfillment of critical medication needs across the global military healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FU284?
SPE2DR26FU284 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FU284 worth?
The government has obligated $23,975 on SPE2DR26FU284.
Is contract SPE2DR26FU284 an order under another contract?
Yes. SPE2DR26FU284 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU284 competed?
The extent of competition for SPE2DR26FU284 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award